This inventor holds 1 USPTO granted patent. Top assignee: Agency for Science, Technology and Research. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Innovations of Inventor Nan Ma
Introduction
Nan Ma is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the area of neurotrophin receptor mediated gene delivery. His work focuses on developing novel solutions that can potentially address various neurological disorders.
Latest Patents
Nan Ma holds a patent for a recombinant polypeptide that is useful for neurotrophin receptor mediated gene delivery and acts as a neurotrophin agonist. This invention provides a unique recombinant polypeptide that includes a nucleic acid binding element and a hairpin motif that selectively binds to a neurotrophin receptor. The recombinant polypeptide can be utilized for the delivery of therapeutic DNA, which is bound to the polypeptide. The hairpin motif can be derived from neurotrophins such as nerve growth factor, brain-derived neurotrophic factor, neurotrophin 3, and neurotrophin 4/5. Additionally, the hairpin motif serves as a neurotrophin agonist, making it applicable for treating disorders responsive to neurotrophin treatment, including neurological disorders and tumors.
Career Highlights
Nan Ma is associated with the Agency for Science, Technology and Research, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on therapeutic applications in medicine.
Collaborations
Some of his notable coworkers include Jieming Zeng and Shu Wang, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Nan Ma's innovative work in recombinant polypeptides showcases his commitment to advancing medical science and addressing critical health challenges. His contributions are paving the way for future developments in gene therapy and neurobiology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
